 |
|
Cyclosporine Inhibits Basic Fibroblast Growth Factor-Driven Proliferation of Human Endothelial Cells and Keratinocytes
Richard J. Sharpe, MD;
Kenneth A. Arndt, MD;
Susan I. Bauer;
Theodore E. Maione, PhD
Arch Dermatol. 1989;125(10):1359-1362.
Abstract
| |
• Keratinocytes and endothelial cells produce basic fibroblast growth factor (b-FGF), and this cytokine is mitogenic for both cell types. Additionally, b-FGF is stored in the vicinity of keratinocytes and endothelial cells in basement membrane and extracellular matrix, and can be displaced from these "buffers" by various stimuli. Displacement of b-FGF by physical stimuli, such as scratching or rubbing, could explain koebnerization in diseases such as psoriasis. It has been shown that the fungal metabolite cyclosporine A will inhibit the proliferation of keratinocytes in vitro when their proliferation is driven by epidermal growth factor (EGF) and/or bovine pituitary extract. Since b-FGF may be both a positive autocrine and paracrine signal involved in the proliferation of both keratinocytes and endothelial cells, we evaluated the effects of cyclosporine on the b-FGF-driven proliferation of these cell types in vitro. We have shown that normal human keratinocyte and endothelial cell proliferation driven by b-FGF alone can be inhibited by cyclosporine A. Concentrations of cyclosporine A achievable in skin after oral administration can significantly inhibit the b-FGF-driven proliferation of both of these cell types. Basic fibroblast growth factor may be an important signal driving both keratinocyte proliferation and angiogenesis in certain disease states, such as psoriasis, as well as aberrant endothelial cell proliferation as is seen in Kaposi's sacoma. The efficacy of cyclosporine A in treating these disease states may be due, at least in part, to the ability of cyclosporine A to interrupt b-FGF-mediated autocrine and paracrine feedback loops acting on and between endothelial cells and keratinocytes.
(Arch Dermatol. 1989;125:1359-1362)
Author Affiliations
From the Department of Dermatology, Beth Israel Hospital, Harvard Medical School, Boston, Mass, and the Repligen Corp, Cambridge, Mass.
Footnotes
Accepted for publication July 7, 1989.
Presented in part at the Annual Meeting of the Society of Investigative Dermatology, Washington, DC, April 1989.
Reprint requests to Department of Dermatology, Beth Israel Hospital, Boston, MA 02215 (Dr Sharpe).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Induction of the unfolded protein response by calcineurin inhibitors: a double-edged sword in renal transplantation
Kitamura
Nephrol Dial Transplant 2009;0:gfp516v1-gfp516.
FULL TEXT
Suppression of NF-{kappa}B by Cyclosporin A and Tacrolimus (FK506) via Induction of the C/EBP Family: Implication for Unfolded Protein Response
Du et al.
J. Immunol. 2009;182:7201-7211.
ABSTRACT
| FULL TEXT
Immunosuppressive Agents and Endothelial Repair : Prednisolone Delays Migration and Cytoskeletal Rearrangement in Wounded Porcine Aortic Monolayers
Fyfe et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1166-1171.
ABSTRACT
| FULL TEXT
Low-Dose Cyclosporine A in the Treatment of Disabling Morphea
Peter et al.
Arch Dermatol 1991;127:1420-1421.
ABSTRACT
Cyclosporine: An Immunosuppressant Affecting Epithelial Cell Proliferation
Kanitakis and Thivolet
Arch Dermatol 1990;126:369-375.
ABSTRACT
|
